| Bioactivity | Spiraprilat is a potent angiotensin-converting enzyme (ACE) inhibitor. Spiraprilat has ability to improve left ventricular (LV) function and metabolism in anesthetized open-chest dogs with acute ventricular failure (ALVF)[1]. |
| Name | Spiraprilat |
| CAS | 83602-05-5 |
| Formula | C20H26N2O5S2 |
| Molar Mass | 438.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nakazawa M, et al. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure. J Cardiovasc Pharmacol. 1993 Oct;22(4):585-93. |
Spiraprilat
CAS: 83602-05-5 F: C20H26N2O5S2 W: 438.56
Spiraprilat is a potent angiotensin-converting enzyme (ACE) inhibitor. Spiraprilat has ability to improve left ventricul
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.